A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis
NCT ID: NCT06407934
Last Updated: 2025-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
1500 participants
INTERVENTIONAL
2024-05-08
2027-03-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objective of this study is to evaluate if those participants who received amlitelimab dose 1 in the parent studies (EFC17559 \[COAST-1\], EFC17560 \[COAST 2\], EFC17561 \[SHORE\]) and were responders can maintain their response either remaining at dose 1 or switching to dose 2 of amlitelimab compared to treatment withdrawal.
Study details include:
The study duration will be up to 68 weeks including a 52-week randomized double-blind period, and a 16-week safety follow-up for participants not entering the LTS17367 (RIVER-AD).
The study duration will be up to 52 weeks for participants entering the LTS17367 \[RIVER-AD\] study at the Week 52 visit of EFC17600 (ESTUARY).
The total treatment duration will be up to 52 weeks. The total number of visits will be up to 15 visits (or 14 visits for those entering LTS17367 \[RIVER-AD\] study).
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Amlitelimab dose 1
Subcutaneous injection as per protocol
Amlitelimab
Pharmaceutical form: Injection solution
Route of administration: Subcutaneous (SC) injection
Amlitelimab dose 2
Subcutaneous injection as per protocol
Amlitelimab
Pharmaceutical form: Injection solution
Route of administration: Subcutaneous (SC) injection
Placebo
Subcutaneous injection as per protocol
Placebo
Pharmaceutical form: Injection solution
Route of administration: SC injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Amlitelimab
Pharmaceutical form: Injection solution
Route of administration: Subcutaneous (SC) injection
Placebo
Pharmaceutical form: Injection solution
Route of administration: SC injection
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must have participated, received study treatment without permanent investigational medicinal product (IMP) discontinuation, and adequately completed the assessments required for the treatment period in one of the three 24-week parent studies EFC17559 (COAST-1), EFC17560 (COAST-2) or EFC17561 (SHORE) for moderate-to-severe AD.
* Able and willing to comply with requested study visit and procedures.
* Body weight must be ≥ 25 kg.
Exclusion Criteria
* Having received any prohibited medication or procedure for AD that resulted in IMP discontinuation in the parent study EFC17559 (COAST-1), EFC17560 (COAST-2) or EFC17561 (SHORE).
* Participants who, during their participation in the parent study EFC17559 (COAST-1) /EFC17560 (COAST-2)/EFC17561 (SHORE), developed an adverse event (AE) or a serious adverse event (SAE) deemed related to amlitelimab, which in the opinion of the Investigator could indicate that continued treatment with amlitelimab may present an unreasonable risk for the participant.
* Participants who have had IMP permanently discontinued for any reason before or at the time of the planned first dose in the EFC17600 (ESTUARY) study.
* Conditions in the parent study EFC17559 (COAST-1)/EFC17560 (COAST-2)/EFC17561 (SHORE) that led to Investigator - or Sponsor-initiated withdrawal of participant from the study (eg, non-compliance, inability to complete study assessments, etc.).
* Participant not suitable for participation, whatever the reason, as judged by the Investigator, including medical or clinical conditions, or participants potentially at risk of noncompliance to study procedures.
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sanofi
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cahaba Dermatology & Skin Health Center- Site Number : 8401066
Birmingham, Alabama, United States
Center for Dermatology and Plastic Surgery- Site Number : 8401119
Scottsdale, Arizona, United States
Scottsdale Clinical Trials- Site Number : 8401149
Scottsdale, Arizona, United States
Eclipse Clinical Research- Site Number : 8401158
Tucson, Arizona, United States
Johnson Dermatology- Site Number : 8401076
Fort Smith, Arkansas, United States
Encino Research Center- Site Number : 8401042
Encino, California, United States
First OC Dermatology- Site Number : 8401025
Fountain Valley, California, United States
Center for Dermatology Clinical Research- Site Number : 8401018
Fremont, California, United States
Marvel Clinical Research- Site Number : 8401102
Huntington Beach, California, United States
Sunwise Clinical Research- Site Number : 8401022
Lafayette, California, United States
Torrance Clinical Research - Narbonne Avenue- Site Number : 8401027
Lomita, California, United States
Dermatology Research Associates - Los Angeles- Site Number : 8401092
Los Angeles, California, United States
LA Universal Research Center- Site Number : 8401064
Los Angeles, California, United States
Northridge Clinical Trials - Northridge- Site Number : 8401080
Northridge, California, United States
Cura Clinical Research - Oxnard- Site Number : 8401142
Oxnard, California, United States
Southern California Dermatology- Site Number : 8401043
Santa Ana, California, United States
Clinical Science Institute- Site Number : 8401028
Santa Monica, California, United States
UConn Health - Farmington- Site Number : 8401115
Farmington, Connecticut, United States
Pediatric Skin Research- Site Number : 8401198
Coral Gables, Florida, United States
St. Jude Clinical Research- Site Number : 8401287
Doral, Florida, United States
Beth Israel Deaconess Medical Center - Fort Myers- Site Number : 8401286
Fort Myers, Florida, United States
Direct Helpers Research Center- Site Number : 8401056
Hialeah, Florida, United States
Encore Medical Research - Hollywood- Site Number : 8401030
Hollywood, Florida, United States
Clever Medical Research- Site Number : 8401160
Miami, Florida, United States
Acevedo Clinical Research Associates- Site Number : 8401088
Miami, Florida, United States
Florida International Research Center- Site Number : 8401091
Miami, Florida, United States
Miami Dermatology and Laser Research - Miami - Southwest 87th Avenue- Site Number : 8401086
Miami, Florida, United States
Anchor Medical Research- Site Number : 8401300
Miami, Florida, United States
Savin Medical Group - Miami Lakes- Site Number : 8401085
Miami Lakes, Florida, United States
Nuline Clinical Trial Center- Site Number : 8401161
Pompano Beach, Florida, United States
Global Clinical Professionals (GCP)- Site Number : 8401045
St. Petersburg, Florida, United States
Clinical Research Trials of Florida- Site Number : 8401023
Tampa, Florida, United States
AllerVie Clinical Research - Columbus- Site Number : 8401104
Columbus, Georgia, United States
Cleaver Medical Group- Site Number : 8401138
Dawsonville, Georgia, United States
First Georgia Physician Group- Site Number : 8401190
Fayetteville, Georgia, United States
Skin Care Physicians of Georgia - Macon- Site Number : 8401034
Macon, Georgia, United States
Javara Research - Thomasville- Site Number : 8401189
Thomasville, Georgia, United States
Rophe Adult & Pediatric Medicine- Site Number : 8401289
Union City, Georgia, United States
NorthShore University Health System - Endeavor Health Medical Group - Skokie - Woods Drive- Site Number : 8401038
Skokie, Illinois, United States
Dawes Fretzin Clinical Research- Site Number : 8401015
Indianapolis, Indiana, United States
Equity Medical - Bowling Green- Site Number : 8401296
Bowling Green, Kentucky, United States
Skin Sciences- Site Number : 8401039
Louisville, Kentucky, United States
MedPharmics - Covington- Site Number : 8401137
Covington, Louisiana, United States
BRCR Global Gretna- Site Number : 8401243
Gretna, Louisiana, United States
Velocity Clinical Research - Lafayette- Site Number : 8401152
Lafayette, Louisiana, United States
MetroBoston Clinical Partners - Brighton- Site Number : 8401128
Brighton, Massachusetts, United States
Henry Ford Hospital- Site Number : 8401044
Detroit, Michigan, United States
Revival Research Institute - Troy- Site Number : 8401012
Troy, Michigan, United States
Oakland Medical Center- Site Number : 8401116
Troy, Michigan, United States
Allergy & Immunology Associates of Ann Arbor- Site Number : 8401078
Ypsilanti, Michigan, United States
SKY Integrative Medical Center/SKYCRNG - Ridgeland- Site Number : 8401058
Ridgeland, Mississippi, United States
Skin Specialists- Site Number : 8401068
Omaha, Nebraska, United States
Jubilee Clinical Research- Site Number : 8401054
Las Vegas, Nevada, United States
Care Access - Hoboken- Site Number : 8401132
Hoboken, New Jersey, United States
The University of New Mexico- Site Number : 8401263
Albuquerque, New Mexico, United States
Equity Medical- Site Number : 8401239
New York, New York, United States
Icahn School of Medicine at Mount Sinai- Site Number : 8401129
New York, New York, United States
Sadick Research Group - New York - Park Avenue- Site Number : 8401050
New York, New York, United States
OptiSkin- Site Number : 8401163
New York, New York, United States
AXIS Clinicals - Fargo- Site Number : 8401196
Fargo, North Dakota, United States
Bexley Dermatology Research- Site Number : 8401051
Bexley, Ohio, United States
Apex Clinical Research Center- Site Number : 8401237
Mayfield Heights, Ohio, United States
Oregon Medical Research Center- Site Number : 8401017
Portland, Oregon, United States
Best Skin Research - Camp Hill- Site Number : 8401031
Camp Hill, Pennsylvania, United States
Paddington Testing Company- Site Number : 8401041
Philadelphia, Pennsylvania, United States
Clinical Research of Philadelphia- Site Number : 8401193
Philadelphia, Pennsylvania, United States
Dermatology Associates of Plymouth Meeting- Site Number : 8401147
Plymouth Meeting, Pennsylvania, United States
Columbia Dermatology & Aesthetics- Site Number : 8401166
Columbia, South Carolina, United States
Tribe Clinical Research - Greenville - Verdae Boulevard- Site Number : 8401225
Greenville, South Carolina, United States
Health Concepts- Site Number : 8401059
Rapid City, South Dakota, United States
Arlington Research Center- Site Number : 8401248
Arlington, Texas, United States
Dermatology Treatment and Research Center- Site Number : 8401164
Dallas, Texas, United States
Derm Texas- Site Number : 8401217
Dallas, Texas, United States
Prolato Clinical Research Center- Site Number : 8401209
Houston, Texas, United States
SMS Clinical Research- Site Number : 8401182
Mesquite, Texas, United States
Synapse Clinical Research - Missouri City- Site Number : 8401148
Missouri City, Texas, United States
Texas Dermatology and Laser Specialists - San Antonio - Oakwell Court- Site Number : 8401131
San Antonio, Texas, United States
Stryde Research - Epiphany Dermatology- Site Number : 8401185
Southlake, Texas, United States
Complete Dermatology - Sugar Land- Site Number : 8401061
Sugar Land, Texas, United States
Tanner Clinic - Layton Antelope A- Site Number : 8401151
Layton, Utah, United States
Care Access - Arlington- Site Number : 8401134
Arlington, Virginia, United States
Virginia Dermatology & Skin Cancer Center- Site Number : 8401047
Norfolk, Virginia, United States
Investigational Site Number : 0320021
Berazategui, Buenos Aires, Argentina
Investigational Site Number : 0320006
Rosario, Santa Fe Province, Argentina
Investigational Site Number : 0320007
Rosario, Santa Fe Province, Argentina
Investigational Site Number : 0320015
Rosario, Santa Fe Province, Argentina
Investigational Site Number : 0320020
San Miguel de Tucumán, Tucumán Province, Argentina
Investigational Site Number : 0320024
San Miguel de Tucumán, Tucumán Province, Argentina
Investigational Site Number : 0320022
Buenos Aires, , Argentina
Investigational Site Number : 0320023
Buenos Aires, , Argentina
Investigational Site Number : 0320011
Buenos Aires, , Argentina
Investigational Site Number : 0320016
Buenos Aires, , Argentina
Investigational Site Number : 0320008
Buenos Aires, , Argentina
Investigational Site Number : 0320001
Buenos Aires, , Argentina
Investigational Site Number : 0320018
Buenos Aires, , Argentina
Investigational Site Number : 0320010
Buenos Aires, , Argentina
Investigational Site Number : 0320002
Buenos Aires, , Argentina
Investigational Site Number : 0320004
Buenos Aires, , Argentina
Investigational Site Number : 0320009
Buenos Aires, , Argentina
Investigational Site Number : 0320019
Buenos Aires, , Argentina
Investigational Site Number : 0320005
Buenos Aires, , Argentina
Investigational Site Number : 0320012
Corrientes, , Argentina
Investigational Site Number : 0320013
Mendoza, , Argentina
Investigational Site Number : 0360010
Westmead, New South Wales, Australia
Investigational Site Number : 0360007
Woolloongabba, Queensland, Australia
Investigational Site Number : 0360008
Melbourne, Victoria, Australia
Investigational Site Number : 0360006
Melbourne, Victoria, Australia
Investigational Site Number : 0361006
Traralgon, Victoria, Australia
Centro de Diagnostico e Pesquisa da Osteoporose do Espirito Santo- Site Number : 0760017
Vitória, Espírito Santo, Brazil
Centro de Pesquisas da Clínica IBIS- Site Number : 0760002
Salvador, Estado de Bahia, Brazil
Hospital São Domingos- Site Number : 0760028
Bequimão, Maranhão, Brazil
Hospital de Clinicas da Universidade Federal do Parana- Site Number : 0760022
Curitiba, Paraná, Brazil
PUC Trials- Nucleo de Pesquisa clinica da Escola de Medicina da PUCPR- Site Number : 0760023
Curitiba, Paraná, Brazil
Irmandade da Santa Casa de Misericórdia de Porto Alegre- Site Number : 0760005
Porto Alegre, Rio Grande do Sul, Brazil
Hospital São Lucas da PUCRS - Porto Alegre - Avenida Ipiranga- Site Number : 0760024
Porto Alegre, Rio Grande do Sul, Brazil
Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto- Site Number : 0760015
Ribeirão Preto, São Paulo, Brazil
Faculdade de Medicina do ABC- Site Number : 0760001
Santo André, São Paulo, Brazil
Clinica de Alergia Martti Antila- Site Number : 0760006
Sorocaba, São Paulo, Brazil
CCBR / IBPClin - Instituto Brasil de Pesquisa Clínica- Site Number : 0760018
Rio de Janeiro, , Brazil
Hospital Alemao Oswaldo Cruz - São Paulo- Site Number : 0760010
São Paulo, , Brazil
Centro de Desenvolvimento em Estudos ClÌnicos Brasil- Site Number : 0760014
São Paulo, , Brazil
Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo- Site Number : 0760012
São Paulo, , Brazil
Investigational Site Number : 1002007
Dupnitsa, , Bulgaria
Investigational Site Number : 1002004
Pleven, , Bulgaria
Investigational Site Number : 1002005
Sofia, , Bulgaria
Investigational Site Number : 1240039
Calgary, Alberta, Canada
Investigational Site Number : 1240031
Edmonton, Alberta, Canada
Investigational Site Number : 1240045
Red Deer, Alberta, Canada
Investigational Site Number : 1240046
Kelowna, British Columbia, Canada
Investigational Site Number : 1240040
Surrey, British Columbia, Canada
Investigational Site Number : 1240030
Surrey, British Columbia, Canada
Investigational Site Number : 1240041
Winnipeg, Manitoba, Canada
Investigational Site Number : 1240033
Ajax, Ontario, Canada
Investigational Site Number : 1240029
London, Ontario, Canada
Investigational Site Number : 1241106
Markham, Ontario, Canada
Investigational Site Number : 1240008
Mississauga, Ontario, Canada
Investigational Site Number : 1241108
Niagara Falls, Ontario, Canada
Investigational Site Number : 1240034
Ottawa, Ontario, Canada
Investigational Site Number : 1240038
Richmond Hill, Ontario, Canada
Investigational Site Number : 1240012
Toronto, Ontario, Canada
Investigational Site Number : 1240035
Toronto, Ontario, Canada
Investigational Site Number : 1241107
Waterloo, Ontario, Canada
Investigational Site Number : 1240006
Québec, Quebec, Canada
Investigational Site Number : 1240028
Regina, Saskatchewan, Canada
Investigational Site Number : 1240036
Saskatoon, Saskatchewan, Canada
Investigational Site Number : 1520004
Valdivia, Los Ríos Region, Chile
Investigational Site Number : 1520009
Osorno, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520013
Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520008
Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520002
Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520003
Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520014
Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520010
Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520011
Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520005
Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520001
Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520015
Quillota, Región de Valparaíso, Chile
Investigational Site Number : 1520006
Viña del Mar, Región de Valparaíso, Chile
Investigational Site Number : 1520012
Talcahuano, Región del Biobío, Chile
Investigational Site Number : 1560042
Beijing, , China
Investigational Site Number : 1560004
Beijing, , China
Investigational Site Number : 1560030
Beijing, , China
Investigational Site Number : 1560050
Changsha, , China
Investigational Site Number : 1560022
Chengdu, , China
Investigational Site Number : 1560060
Chengdu, , China
Investigational Site Number : 1560068
Chengdu, , China
Investigational Site Number : 1560057
Chongqing, , China
Investigational Site Number : 1560065
Chongqing, , China
Investigational Site Number : 1560043
Fuzhou, , China
Investigational Site Number : 1560021
Guangzhou, , China
Investigational Site Number : 1560025
Guangzhou, , China
Investigational Site Number : 1560058
Guangzhou, , China
Investigational Site Number : 1560044
Hangzhou, , China
Investigational Site Number : 1560002
Hangzhou, , China
Investigational Site Number : 1560006
Hangzhou, , China
Investigational Site Number : 1560029
Hangzhou, , China
Investigational Site Number : 1560007
Jinan, , China
Investigational Site Number : 1560051
Nanchang, , China
Investigational Site Number : 1560024
Ningbo, , China
Investigational Site Number : 1560001
Shanghai, , China
Investigational Site Number : 1560005
Shanghai, , China
Investigational Site Number : 1560041
Shenyang, , China
Investigational Site Number : 1560026
Shenyang, , China
Investigational Site Number : 1560064
Shenzhen, , China
Investigational Site Number : 1560023
Wenzhou, , China
Investigational Site Number : 1560049
Wuhan, , China
Investigational Site Number : 1560003
Wuxi, , China
Investigational Site Number : 1560028
Zhenjiang, , China
Investigational Site Number : 2032106
Kutná Hora, , Czechia
Investigational Site Number : 2032105
Nový Jičín, , Czechia
Investigational Site Number : 2030010
Olomouc, , Czechia
Investigational Site Number : 2032104
Ostrava, , Czechia
Investigational Site Number : 2030009
Pilsen, , Czechia
Investigational Site Number : 2030008
Prague, , Czechia
Investigational Site Number : 2030011
Prague, , Czechia
Investigational Site Number : 2030006
Prague, , Czechia
Investigational Site Number : 2080002
Aalborg, , Denmark
Investigational Site Number : 2080001
Aarhus, , Denmark
Investigational Site Number : 2080003
Herlev, , Denmark
Investigational Site Number : 2500008
Antony, , France
Investigational Site Number : 2500013
Nice, , France
Investigational Site Number : 2500003
Paris, , France
Investigational Site Number : 2500006
Pierre-Bénite, , France
Investigational Site Number : 2500007
Reims, , France
Investigational Site Number : 2500010
Romans-sur-Isère, , France
Investigational Site Number : 2500012
Rouen, , France
Investigational Site Number : 2500002
Toulouse, , France
Investigational Site Number : 2760020
Augsburg, , Germany
Investigational Site Number : 2760009
Bad Bentheim, , Germany
Investigational Site Number : 2760017
Hamburg, , Germany
Investigational Site Number : 2760021
Hamburg, , Germany
Investigational Site Number : 2762208
Kiel, , Germany
Investigational Site Number : 2760016
Mainz, , Germany
Investigational Site Number : 2762201
Münster, , Germany
Investigational Site Number : 2760019
Witten, , Germany
Investigational Site Number : 3000001
Athens, , Greece
Investigational Site Number : 3000002
Thessaloniki, , Greece
Investigational Site Number : 3560001
Ahmedabad, , India
Investigational Site Number : 3560005
Belagavi, , India
Investigational Site Number : 3560004
Chandigarh, , India
Investigational Site Number : 3560006
Faridabad, , India
Investigational Site Number : 3560007
Kolkata, , India
Investigational Site Number : 3560002
Nagpur, , India
Investigational Site Number : 3560003
Pune, , India
Investigational Site Number : 3760004
Afula, , Israel
Investigational Site Number : 3760005
Beersheba, , Israel
Investigational Site Number : 3760001
Haifa, , Israel
Investigational Site Number : 3760003
Jerusalem, , Israel
Investigational Site Number : 3760006
Petah Tikva, , Israel
Investigational Site Number : 3760002
Petah Tikva, , Israel
Investigational Site Number : 3800003
Milan, Milano, Italy
Investigational Site Number : 3800018
Rozzano, Milano, Italy
Investigational Site Number : 3800013
Rome, Roma, Italy
Investigational Site Number : 3800012
Bologna, , Italy
Investigational Site Number : 3800009
Catania, , Italy
Investigational Site Number : 3800011
L’Aquila, , Italy
Investigational Site Number : 3800008
Pisa, , Italy
Investigational Site Number : 3800022
Vicenza, , Italy
Investigational Site Number : 3920009
Chitose, Hokkaido, Japan
Investigational Site Number : 3923114
Obihiro, Hokkaido, Japan
Investigational Site Number : 3920008
Sapporo, Hokkaido, Japan
Investigational Site Number : 3920006
Kobe, Hyōgo, Japan
Investigational Site Number : 3920005
Sagamihara, Kanagawa, Japan
Investigational Site Number : 3923113
Yokohama, Kanagawa, Japan
Investigational Site Number : 3920010
Miyagi-gun, Miyagi, Japan
Investigational Site Number : 3920011
Sendai, Miyagi, Japan
Investigational Site Number : 3923109
Habikino, Osaka, Japan
Investigational Site Number : 3923110
Sakai, Osaka, Japan
Investigational Site Number : 3920002
Iruma, Saitama, Japan
Investigational Site Number : 3923106
Mibu, Tochigi, Japan
Investigational Site Number : 3920004
Chūō, Tokyo, Japan
Investigational Site Number : 3923107
Minato, Tokyo, Japan
Investigational Site Number : 3920001
Tachikawa, Tokyo, Japan
Investigational Site Number : 3923108
Kagoshima, , Japan
Investigational Site Number : 3923102
Kyoto, , Japan
Investigational Site Number : 3920003
Kyoto, , Japan
Investigational Site Number : 4840005
Monterrey, Nuevo León, Mexico
Investigational Site Number : 4840012
Aguascalientes, , Mexico
Investigational Site Number : 4840009
Durango, , Mexico
Investigational Site Number : 4840003
Veracruz, , Mexico
Investigational Site Number : 6162406
Krakow, Lesser Poland Voivodeship, Poland
Investigational Site Number : 6160010
Tarnów, Lesser Poland Voivodeship, Poland
Investigational Site Number : 6160004
Lublin, Lublin Voivodeship, Poland
Investigational Site Number : 6160002
Lodz, Lódzkie, Poland
Investigational Site Number : 6160009
Warsaw, Masovian Voivodeship, Poland
Investigational Site Number : 6160007
Warsaw, Masovian Voivodeship, Poland
Investigational Site Number : 6160006
Gdansk, Pomeranian Voivodeship, Poland
Investigational Site Number : 6160003
Katowice, Silesian Voivodeship, Poland
Investigational Site Number : 6200005
Lisbon, , Portugal
Investigational Site Number : 6200004
Lisbon, , Portugal
Investigational Site Number : 6200001
Lisbon, , Portugal
Investigational Site Number : 6200003
Porto, , Portugal
Investigational Site Number : 7100015
Benoni, , South Africa
Investigational Site Number : 7100010
Cape Town, , South Africa
Investigational Site Number : 7100009
Cape Town, , South Africa
Investigational Site Number : 7100012
Durban, , South Africa
Investigational Site Number : 7100001
Durban, , South Africa
Investigational Site Number : 7100007
Johannesburg, , South Africa
Investigational Site Number : 7100003
Pretoria, , South Africa
Investigational Site Number : 4100008
Daegu, Daegu, South Korea
Investigational Site Number : 4100012
Gwangju, Gwangju, South Korea
Investigational Site Number : 4100002
Ansan-si, Gyeonggi-do, South Korea
Investigational Site Number : 4100014
Seongnam-si, Gyeonggi-do, South Korea
Investigational Site Number : 4100009
Suwon, Gyeonggi-do, South Korea
Investigational Site Number : 4100003
Yangsan, Gyeongsangnam-do, South Korea
Investigational Site Number : 4100015
Bupyeong-gu, Incheon-gwangyeoksi, South Korea
Investigational Site Number : 4100010
Seoul, Seoul-teukbyeolsi, South Korea
Investigational Site Number : 4100013
Seoul, Seoul-teukbyeolsi, South Korea
Investigational Site Number : 4100007
Seoul, Seoul-teukbyeolsi, South Korea
Investigational Site Number : 4100006
Seoul, Seoul-teukbyeolsi, South Korea
Investigational Site Number : 4100011
Seoul, Seoul-teukbyeolsi, South Korea
Investigational Site Number : 4100017
Seoul, Seoul-teukbyeolsi, South Korea
Investigational Site Number : 7240010
Esplugues de Llobregat, Barcelona [Barcelona], Spain
Investigational Site Number : 7240008
Bilbao, Basque Country, Spain
Investigational Site Number : 7240012
Las Palmas de Gran Canaria, Las Palmas, Spain
Investigational Site Number : 7240015
Pamplona, Navarre, Spain
Investigational Site Number : 7240014
Vigo, Pontevedra [Pontevedra], Spain
Investigational Site Number : 7240020
Seville, Sevilla, Spain
Investigational Site Number : 7240023
Burjassot - Valencia, Valenciana, Comunidad, Spain
Investigational Site Number : 7242505
Alicante, , Spain
Investigational Site Number : 7240018
Granada, , Spain
Investigational Site Number : 7240019
Granada, , Spain
Investigational Site Number : 7240029
Madrid, , Spain
Investigational Site Number : 7242503
Madrid, , Spain
Investigational Site Number : 7520006
Älvsjö, , Sweden
Investigational Site Number : 7520001
Örebro, , Sweden
Investigational Site Number : 1583201
Kaohsiung City, , Taiwan
Investigational Site Number : 1583202
Taichung, , Taiwan
Investigational Site Number : 1580001
Taipei, , Taiwan
Investigational Site Number : 1580003
Taipei, , Taiwan
Investigational Site Number : 7920001
Antalya, , Turkey (Türkiye)
Investigational Site Number : 7920008
Gaziantep, , Turkey (Türkiye)
Investigational Site Number : 7920005
Istanbul, , Turkey (Türkiye)
Investigational Site Number : 7920006
Istanbul, , Turkey (Türkiye)
Investigational Site Number : 7920002
Istanbul, , Turkey (Türkiye)
Investigational Site Number : 7920009
Istanbul, , Turkey (Türkiye)
Investigational Site Number : 7920004
Kayseri, , Turkey (Türkiye)
Investigational Site Number : 7920011
Mersin, , Turkey (Türkiye)
Investigational Site Number : 7920007
Samsun, , Turkey (Türkiye)
Investigational Site Number : 8260003
Portsmouth, Hampshire, United Kingdom
Investigational Site Number : 8260004
Leicester, Leicestershire, United Kingdom
Investigational Site Number : 8262601
London, London, City of, United Kingdom
Investigational Site Number : 8262602
London, London, City of, United Kingdom
Investigational Site Number : 8260006
Glasgow, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Trial Transparency email recommended (Toll free for US & Canada)
Role: CONTACT
Phone: 800-633-1610
Email: [email protected]
Related Links
Access external resources that provide additional context or updates about the study.
EFC17600 Plain Language Results Summary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1290-9215
Identifier Type: REGISTRY
Identifier Source: secondary_id
2023-508096-36
Identifier Type: REGISTRY
Identifier Source: secondary_id
EFC17600
Identifier Type: -
Identifier Source: org_study_id